Norris Financial Group, LLC’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $345K | Sell |
|
|||||
|
2025
Q4 | $411K | Sell |
|
|||||
|
2025
Q3 | $515K | Sell |
|
|||||
|
2025
Q2 | $473K | Buy |
|
|||||
|
2025
Q1 | $329K | Buy |
|
|||||
|
2024
Q4 | $258K | Sell |
|
|||||
|
2024
Q3 | $486K | Buy |
|
|||||
|
2024
Q2 | $546K | Sell |
|
|||||
|
2024
Q1 | $856K | Sell |
|
|||||
|
2023
Q4 | $931K | Buy |
|
|||||
|
2023
Q3 | $656K | Buy |
|
|||||
|
2023
Q2 | $679K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $220K | Buy |
|